Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI
- PMID: 37039688
- DOI: 10.1148/radiol.222276
Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI
Abstract
Background Clinically significant prostate cancer (PCa) diagnosis at MRI requires accurate and efficient radiologic interpretation. Although artificial intelligence may assist in this task, lack of transparency has limited clinical translation. Purpose To develop an explainable artificial intelligence (XAI) model for clinically significant PCa diagnosis at biparametric MRI using Prostate Imaging Reporting and Data System (PI-RADS) features for classification justification. Materials and Methods This retrospective study included consecutive patients with histopathologic analysis-proven prostatic lesions who underwent biparametric MRI and biopsy between January 2012 and December 2017. After image annotation by two radiologists, a deep learning model was trained to detect the index lesion; classify PCa, clinically significant PCa (Gleason score ≥ 7), and benign lesions (eg, prostatitis); and justify classifications using PI-RADS features. Lesion- and patient-based performance were assessed using fivefold cross validation and areas under the receiver operating characteristic curve. Clinical feasibility was tested in a multireader study and by using the external PROSTATEx data set. Statistical evaluation of the multireader study included Mann-Whitney U and exact Fisher-Yates test. Results Overall, 1224 men (median age, 67 years; IQR, 62-73 years) had 3260 prostatic lesions (372 lesions with Gleason score of 6; 743 lesions with Gleason score of ≥ 7; 2145 benign lesions). XAI reliably detected clinically significant PCa in internal (area under the receiver operating characteristic curve, 0.89) and external test sets (area under the receiver operating characteristic curve, 0.87) with a sensitivity of 93% (95% CI: 87, 98) and an average of one false-positive finding per patient. Accuracy of the visual and textual explanations of XAI classifications was 80% (1080 of 1352), confirmed by experts. XAI-assisted readings improved the confidence (4.1 vs 3.4 on a five-point Likert scale; P = .007) of nonexperts in assessing PI-RADS 3 lesions, reducing reading time by 58 seconds (P = .009). Conclusion The explainable AI model reliably detected and classified clinically significant prostate cancer and improved the confidence and reading time of nonexperts while providing visual and textual explanations using well-established imaging features. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Chapiro in this issue.
Comment in
-
Explainable AI for Prostate MRI: Don't Trust, Verify.Radiology. 2023 May;307(4):e230574. doi: 10.1148/radiol.230574. Epub 2023 Apr 11. Radiology. 2023. PMID: 37039689 Free PMC article. No abstract available.
Similar articles
-
MRI-based Deep Learning Algorithm for Assisting Clinically Significant Prostate Cancer Detection: A Bicenter Prospective Study.Radiology. 2025 Mar;314(3):e232788. doi: 10.1148/radiol.232788. Radiology. 2025. PMID: 40067105
-
A Cascaded Deep Learning-Based Artificial Intelligence Algorithm for Automated Lesion Detection and Classification on Biparametric Prostate Magnetic Resonance Imaging.Acad Radiol. 2022 Aug;29(8):1159-1168. doi: 10.1016/j.acra.2021.08.019. Epub 2021 Sep 28. Acad Radiol. 2022. PMID: 34598869 Free PMC article.
-
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.Lancet Oncol. 2024 Jul;25(7):879-887. doi: 10.1016/S1470-2045(24)00220-1. Epub 2024 Jun 11. Lancet Oncol. 2024. PMID: 38876123 Free PMC article. Clinical Trial.
-
Multiparametric MRI in detection and staging of prostate cancer.Dan Med J. 2017 Feb;64(2):B5327. Dan Med J. 2017. PMID: 28157066 Review.
-
Artificial Intelligence in Magnetic Resonance Imaging-based Prostate Cancer Diagnosis: Where Do We Stand in 2021?Eur Urol Focus. 2022 Mar;8(2):409-417. doi: 10.1016/j.euf.2021.03.020. Epub 2021 Mar 25. Eur Urol Focus. 2022. PMID: 33773964 Review.
Cited by
-
Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI.Radiology. 2024 May;311(2):e230750. doi: 10.1148/radiol.230750. Radiology. 2024. PMID: 38713024 Free PMC article.
-
The Role of Radiomics in the Prediction of Clinically Significant Prostate Cancer in the PI-RADS v2 and v2.1 Era: A Systematic Review.Cancers (Basel). 2024 Aug 24;16(17):2951. doi: 10.3390/cancers16172951. Cancers (Basel). 2024. PMID: 39272809 Free PMC article. Review.
-
Prostate Cancer Detection from MRI Using Efficient Feature Extraction with Transfer Learning.Prostate Cancer. 2024 May 16;2024:1588891. doi: 10.1155/2024/1588891. eCollection 2024. Prostate Cancer. 2024. PMID: 38783970 Free PMC article. Review.
-
Towards Transparent Healthcare: Advancing Local Explanation Methods in Explainable Artificial Intelligence.Bioengineering (Basel). 2024 Apr 12;11(4):369. doi: 10.3390/bioengineering11040369. Bioengineering (Basel). 2024. PMID: 38671790 Free PMC article. Review.
-
Prostate cancer classification using 3D deep learning and ultrasound video clips: a multicenter study.Front Oncol. 2025 Jun 27;15:1582035. doi: 10.3389/fonc.2025.1582035. eCollection 2025. Front Oncol. 2025. PMID: 40657247 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous